BioSpace News Archive

AccurKardia announced today that its flagship product, the AccurECG™ Analysis System (“AccurECG” or the “System”), has been granted FDA 510(k) clearance.

CoJourney Inc. a global innovator in manufacturing and development of cell and gene therapies is pleased to announce completion of a $30 M Series A financing and expansion of its US organization and commercial manufacturing capabilities.

Adial Pharmaceuticals, Inc. as well as an update on the Company’s current clinical development plan based on guidance received.

Vaxcyte, Inc. today announced that the ongoing Phase 2 study of VAX-24 in healthy infants is advancing to the second and final stage of the study. The independent Data Safety Monitoring Board approved advancing to the second stage of the study following the review of the safety and tolerability results from the first stage.

Salarius Pharmaceuticals, Inc. announces U.S. Food and Drug Administration (FDA) clearance of the company’s investigational new drug (IND) application to commence a Phase 1 clinical trial with SP-3164 in patients with relapsed/refractory non-Hodgkin lymphoma (NHL).

Microbot Medical Inc. announced that Irene Bargellini, M.D., an interventional radiologist and Chair of the Diagnostic and Interventional Radiology Department at Candiolo Cancer Institute in Turin, Italy, has joined the Company’s Scientific Advisory Board.

Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd., a global specialty pharmaceutical company based in Japan, announces the completion of its new North America headquarters at 510 Carnegie Center in Princeton, NJ.

NeuroMetrix, Inc. announced expansion of its sales force to drive further adoption of Quell® Fibromyalgia, which is the first and only medical device authorized by the U.S. Food and Drug Administration to help reduce the symptoms of fibromyalgia.

Radon Medical Imaging announced it has acquired Tristate Biomedical Solutions, LLC, a provider of medical equipment sales and services for new, used and refurbished imaging and biomedical equipment, with a specialty in C-Arms, X-Ray, as well as other imaging equipment.

NeuroSense Therapeutics Ltd. announced it will participate in two upcoming conferences that aim to advance treatments and solutions to improve the lives of people living with amyotrophic lateral sclerosis.